Home Mainline IPOs Dr Agarwals Healthcare IPO
Orion Industries logo

Dr Agarwals Healthcare IPO

Open MainLine
BSE,NSE 29 January - 31 January 2025
Dr. Agarwal's Health Care Limited IPO is a book build issue of 3027.26 Cr. The issue is a combination of fresh issue of 7462686 shares aggregating to 300 Cr and offer for sale of 67842284 shares aggregating to 2727.26 Cr. Dr. Agarwal's Health Care Limited IPO opened for subscription on Jan 29, 2025 and closed on Jan 31, 2025. The allotment for the this IPO was finalized on Feb 03, 2025. IPO was listed on NSE and BSE on Feb 04, 2025. Dr. Agarwal's Health Care Limited IPO is set issue price band at ₹382 to ₹402 per share.

Current GMP

₹-4 (-1.00%)

Price Band

₹ 382 – 402

Lot Size

35

Issue Size

₹3027.26 Cr

Minimum Investment

₹14070 (35 Shares)

Listing Date

04 February 2025

Subscription

1.55x

About the Company

Dr. Agarwal's Health Care Limited is a leading provider of eye care services in India, offering a comprehensive range of treatments including cataract surgeries, refractive surgeries (such as LASIK), and other eye-related surgeries. The company also provides consultations, diagnoses, non-surgical treatments, and sells optical products, contact lenses, and pharmaceuticals related to eye care. As of September 30, 2024, Dr. Agarwal's Health Care holds a 25% market share in India's eye care service market and operates the largest network of eye care facilities in the country, with 209 locations.

The company's network is organized in a "hub and spoke" model, consisting of 28 Tertiary Facilities (including three centers of excellence), 165 Secondary Facilities, and 53 Primary Facilities, across 117 cities in India. This model enhances accessibility and operational efficiency. Dr. Agarwal's Health Care also has an international presence, operating 16 facilities in nine African countries.

The company serves millions of patients annually, with over 2.13 million patients and 220,523 surgeries performed in FY 2024. It is projected to grow with the expanding Indian eye care market, which is expected to reach ₹550–650 billion by 2028. The company is led by Dr. Amar Agarwal, a renowned ophthalmologist with over 35 years of experience.

In addition to its eye care services, the company focuses on clinical excellence and standardization across its network, supported by a skilled team of doctors and institutional investors, including Temasek Holdings and TPG. Dr. Agarwal’s Health Care is well-positioned to continue its growth in India and internationally, capitalizing on the increasing demand for eye care services.

Promoters

  1.  Dr. Amar Agarwal
  2.  Dr. Athiya Agarwal
  3.  Dr Adil Agarwal
  4.  Dr. Anosh Agarwal
  5.  Dr Ashvin Agarwal
  6.  Dr. Ashar Agarwal
  7.  Dr. Amar Agarwal Family Trust
  8.  Dr Adil Agarwal Family Trust
  9.  Dr. Anosh Agarwal Family Trust
  10.  Dr Ashvin Agarwal Family Trust
  11.  Dr. Ashar Agarwal Family Trust
  12.  Dr Agarwal’s Eye Institute 
  13.  Dr Agarwal's Eye Institute Private Limited
Promoters Holding

Holding Pre Issue

37.72%

Holding Post Issue

32.50%

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:

  1. Repayment/prepayment, in part or full, of certain of the borrowings and
  2. General corporate purposes and unidentified inorganic acquisition.

Address / Contact Info

Dr. Agarwal's Health Care Limited
1st Floor, Buhari Towers,
No.4, Moores Road, Off
Greams Road, Near Asan
Memorial School, 
Chennai 600006, Tamil Nadu

Phone: +91 44 4378 7777
Email: secretarial@dragarwal.com
Website: https://dragarwals.co.in/

IPO Snapshot

Face Value₹1 per share
Price Band₹ 382 – 402
Lot Size35
Issue TypeBook-building IPO
Sale Type
Fresh Issue₹ 300.00 Cr
Offer for Sale₹ 2,727.26 Cr
Total Issue Size₹ 3,027.26 Cr
Listing AtBSE,NSE
Industry
Sector
QIB Quota0%
BNII Quota0%
SNII Quota0%
Retail Quota0%

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

Dr Agarwals Healthcare IPO is a Book-building IPO worth ₹3027.26 crores. The price band is ₹382 to 402 per share. The IPO opens on Wed, Jan 29, 2025 and closes on Fri, Jan 31, 2025. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.

The Dr Agarwals Healthcare IPO opens on Wed, Jan 29, 2025 and closes on Fri, Jan 31, 2025

Dr Agarwals Healthcare IPO Price Band is ₹382 to 402.

Dr Agarwals Healthcare IPO lot size is 35, and the minimum amount required for application is ₹14070.

The minimum investment for Dr Agarwals Healthcare IPO is approximately ₹14070 based on the upper price band.

To apply for the Dr Agarwals Healthcare IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Fri, Jan 31, 2025. After submission, funds are blocked until the basis of allotment of Dr Agarwals Healthcare IPO is finalised.

Dr Agarwals Healthcare IPO issue size is ₹3027.26 crores.

Dr Agarwals Healthcare IPO allotment date is Sat, Jun 27, 2026.

The registrar for Dr Agarwals Healthcare IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website for IPO allotment status, refund processing, and other queries related to Dr Agarwals Healthcare IPO through their official website or helpline.

The Dr Agarwals Healthcare IPO GMP (Grey Market Premium) is ₹-4 as of Tue, Feb 4, 2025. Based on the upper price band of ₹402 per share, the estimated Dr Agarwals Healthcare IPO listing price is ₹398, indicating a potential listing gain of approximately 31% over the issue price.